Teva and J&J settle Ortho Tri-Cyclen Lo litigation
28 July 2009
Nancy Faigen
nancy.faigen@informausa.com
Teva Pharmaceutical Industries has agreed to settle an ongoing patent infringement lawsuit with
Johnson & Johnson over Teva's generic version of J&J's Ortho Tri-Cyclen Lo (norgestimate plus ethinylestradiol).
Teva briefly sold its version in the US with an "at risk" launch on July 1st, as...
Please Login to read the full article.